Development of a RadioImmunoTheranostic Agent Targeting LRRC15 - a TGFβ-driven Biomarker Specific to Mesenchymal Stem Cell Derived Cancer Cells and Tumor Stroma
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.